Sante Ventures

Sante Ventures is a life sciences venture capital firm that invests exclusively in early-stage companies developing innovative medical technologies or healthcare delivery models. Founded in 2006, the firm focuses on backing startups at the forefront of life sciences to advance medical innovation.

Joe Cunningham

Founding Managing Director

David Kaufman

COO

Omar Khalil

Managing Director

Dennis Mcwilliams

Managing Director

Past deals in Mechanical Engineering

Endovascular Engineering

Series B in 2025
Endovascular Engineering is a preclinical stage company dedicated to advancing innovative mechanical thrombectomy solutions for peripheral medical conditions. The firm specializes in the development of clot removal technologies specifically designed to address venous thromboembolism, which encompasses critical health issues such as pulmonary embolism and deep vein thrombosis. By focusing on these areas, Endovascular Engineering aims to equip healthcare professionals with efficient and effective tools to enhance patient outcomes in the management of these vascular conditions.

Endovascular Engineering

Series A in 2022
Endovascular Engineering is a preclinical stage company dedicated to advancing innovative mechanical thrombectomy solutions for peripheral medical conditions. The firm specializes in the development of clot removal technologies specifically designed to address venous thromboembolism, which encompasses critical health issues such as pulmonary embolism and deep vein thrombosis. By focusing on these areas, Endovascular Engineering aims to equip healthcare professionals with efficient and effective tools to enhance patient outcomes in the management of these vascular conditions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.